Offering a nutritional formula by enriched soup

Offering a nutritional formula by enriched soup (extra useful) with anti-inflammatory and immunity booster with optimal taste in advanced local gastrointestinal cancer Patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190907044716N1

Enrollment

Registered

2019-11-28

Start date

2019-09-23

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced local gastrointestinal cancer. Malignant neoplasm of ill-defined sites within the digestive system

Interventions

Intervention 1: Intervention group: Patients with advanced local gastrointestinal cancer. Step One: Provide a formulation of a beneficial nutrient.Step Two: Preparation of the desired food with a form

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with advanced local gastrointestinal cancer

Exclusion criteria

Exclusion criteria: Patients with other cancers

Design outcomes

Primary

Measure	Time frame
Metalo peroxidase. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;IL1. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;IL6. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Tumor necrosis factor alpha (TNFa). Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Quality of Life. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on SF36 test.;Albumin. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on the calorimetric test.;Lymphocytes. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on flow cytometry kit.;Body mass index. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Weight in kg / squared the person's height in meters ( kg/m2).;MDA. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Mir-638. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Real-Time Polymerase Chain Reaction.;Protein Carbonylated PrC. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Bradford test.;8-ohdg. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Oxidant-Antioxidant (PAB). Timepoint: At the beginning of the study, half of the treatment and on the last day	—

Measure

Time frame

Metalo peroxidase. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;IL1. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;IL6. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Tumor necrosis factor alpha (TNFa). Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Quality of Life. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on SF36 test.;Albumin. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on the calorimetric test.;Lymphocytes. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on flow cytometry kit.;Body mass index. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Weight in kg / squared the person's height in meters ( kg/m2).;MDA. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Mir-638. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Real-Time Polymerase Chain Reaction.;Protein Carbonylated PrC. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Bradford test.;8-ohdg. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Elisa Test.;Oxidant-Antioxidant (PAB). Timepoint: At the beginning of the study, half of the treatment and on the last day

—

Secondary

Measure	Time frame
Quality of Life. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Based on SF36 test.;Complications. Timepoint: At the beginning of the study, half of the treatment and on the last day of treatment. Method of measurement: Nutrition and Digestive Counseling.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Javanmard

Shahid Beheshti University of Medical Sciences

ajm93dr@gmail.com+98 21 2243 9924

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026